Bone markers and cardiovascular risk in type 2 diabetes patients.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Zwakenberg, Sabine Rvan der Schouw, Yvonne T
Schalkwijk, Casper G
Spijkerman, Annemieke M W
Beulens, Joline W J
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Bone markers and cardiovascular risk in type 2 diabetes patients.Published in
Cardiovasc Diabetol 2018; 17(1):45Publiekssamenvatting
Vascular calcifications are associated with a three- to fourfold increased risk of cardiovascular disease (CVD) and are highly prevalent in type 2 diabetes patients. Emerging evidence indicates that vascular calcification is a process of active bone formation regulated by stimulators and inhibitors of calcification. Therefore, this study aimed to evaluate whether six bone markers are associated with CVD risk in patients with type 2 diabetes.PMID
29571288ae974a485f413a2113503eed53cd6c53
10.1186/s12933-018-0691-2
Scopus Count
Collections
Related articles
- Association between bone metabolism regulators and arterial stiffness in type 2 diabetes patients.
- Authors: Sharif S, Bots ML, Schalkwijk C, Stehouwer CDA, Visseren FLJ, Westerink J, SMART study group.
- Issue date: 2018 Dec
- Plasma advanced glycation end products are associated with incident cardiovascular events in individuals with type 2 diabetes: a case-cohort study with a median follow-up of 10 years (EPIC-NL).
- Authors: Hanssen NM, Beulens JW, van Dieren S, Scheijen JL, van der A DL, Spijkerman AM, van der Schouw YT, Stehouwer CD, Schalkwijk CG
- Issue date: 2015 Jan
- Matrix Gla protein species and risk of cardiovascular events in type 2 diabetic patients.
- Authors: Dalmeijer GW, van der Schouw YT, Magdeleyns EJ, Vermeer C, Verschuren WM, Boer JM, Beulens JW
- Issue date: 2013 Nov
- Serum osteoprotegerin: bone or cardiovascular marker in Type 2 diabetes males?
- Authors: Rozas Moreno P, Reyes García R, García-Martín A, Varsavsky M, García-Salcedo JA, Muñoz-Torres M
- Issue date: 2013 Jan
- Novel Biomarkers to Improve the Prediction of Cardiovascular Event Risk in Type 2 Diabetes Mellitus.
- Authors: van der Leeuw J, Beulens JW, van Dieren S, Schalkwijk CG, Glatz JF, Hofker MH, Verschuren WM, Boer JM, van der Graaf Y, Visseren FL, Peelen LM, van der Schouw YT
- Issue date: 2016 May 31